The Low-Expression Variant of FABP4 Is Associated With Cardiovascular Disease in Type 1 Diabetes-Reference-Cited by-同舟云学术

The Low-Expression Variant of FABP4 Is Associated With Cardiovascular Disease in Type 1 Diabetes

Published:2021-07-09 Issue:10 Volume:70 Page:2391-2401
ISSN:0012-1797
Container-title:Diabetes
language:en
Short-container-title:Diabetes

Author:

Dahlström Emma H.^ORCID,Saksi Jani,Forsblom Carol,Uglebjerg Nicoline,Mars Nina,Thorn Lena M.,Harjutsalo Valma^ORCID,Rossing Peter,Ahluwalia Tarunveer S.,Lindsberg Perttu J.,Sandholm Niina^ORCID,Groop Per-Henrik^ORCID

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference48 articles.

1. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study

2. Type 1 Diabetes Mellitus and Cardiovascular Disease

3. Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes;Harjutsalo;Diabetes Obes Metab,2018

4. Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland

5. Temporal patterns in overweight and obesity in Type 1 diabetes

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential safety implications of fatty acid-binding protein inhibition;Toxicology and Applied Pharmacology;2024-10

2. Whole-genome sequencing identifies variants in ANK1, LRRN1, HAS1, and other genes and regulatory regions for stroke in type 1 diabetes;Scientific Reports;2024-06-11

3. A New Insight into Fatty Acid Binding Protein 4 Mechanisms and Therapeutic Implications in Obesity‐Associated Diseases: A Mini Review;Molecular Nutrition & Food Research;2024-04

4. Temporal Responses of a Low-Energy Meal Replacement Plan or Exercise Training on Cardiovascular Function and Fibro-Inflammatory Markers in People with Type 2 Diabetes—A Secondary Analysis of the “Diabetes Interventional Assessment of Slimming or Training to Lessen Inconspicuous Cardiovascular Dysfunction” Study;Hearts;2024-03-16

5. Structure-guided engineering and molecular simulations to design a potent monoclonal antibody to target aP2 antigen for adaptive immune response instigation against type 2 diabetes;Frontiers in Immunology;2024-03-08